PAI Is Said to Prepare $1.2 Billion Sale of Drugmaker Ethypharm
NeutralFinancial Markets

Private equity firm PAI Partners is reportedly preparing to sell French drugmaker Ethypharm, which specializes in pain and addiction treatments. This move could significantly impact the pharmaceutical landscape, especially in the areas of pain management and addiction recovery, as Ethypharm's expertise is crucial in these fields.
— Curated by the World Pulse Now AI Editorial System